Bisphosphonates to Prevent Osteoporosis in Men Receiving Androgen Deprivation Therapy for Prostate Cancer

By Smith M.R.  

Drugs & Aging, Vol. 20, Iss. 3, 2003-01 ,pp. : 175-183

Adis International

Access to resources Recommend Favorite

A Review on the Effects of Androgen Deprivation Therapy (ADT) on Bone Health Status in Men with Prostate Cancer

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 17, Iss. 4, 2017-11 ,pp. : 276-284

Bentham Science Publishers

Access to resources Recommend Favorite

Annual zoledronic acid may be sufficient to prevent bone loss induced by gonadotrophin-releasing hormone agonist treatment in men with prostatic cancer

By  

Inpharma, Vol. 1, Iss. 1581, 2007-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Antiepileptics associated with hip bone loss in elderly men

By  

Reactions Weekly, Vol. 1, Iss. 1223, 2008-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Are Patients on Long‐Term Corticosteroids Receiving Bone Loss Therapy?

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 36, Iss. 1, 2006-03 ,pp. : 29-31

John Wiley & Sons Inc

Access to resources Recommend Favorite